Jumalon, Jesee C.
HRN: 28-01-02 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/28/2025
11/04/2025
IV
500mg
Q8h
AMOEBIASIS
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes